van Eijk and Steyn et al. report that oral trimetazidine is safe and well tolerated in amyotrophic lateral sclerosis patients, significantly reducing oxida
It's estimated that 3,000 Australians are diagnosed with MND each year. MND affects your mobility, speech and eventually your ability to swallow and breathe. There is no effective treatment to slow...
Background and purpose Loss of appetite contributes to weight loss and faster disease progression in amyotrophic lateral sclerosis (ALS). Impairment of appetite control in ALS may include altered...